ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CLA1343 |
|
1384260-65-4 |
Aducanumab (Anti-Amyloid-β ) 95+% |
— | |
CLA1279 |
|
1095207-05-8 |
Crenezumab (Anti-Amyloid Beta) 95+% |
— | |
CLA1224 |
|
955085-14-0 |
Solanezumab (Anti-Amyloid-β) 95+% |
— | |
CLA1192 |
|
1260393-98-3 |
Lecanemab (Anti-Amyloid Beta) 95+% |
— | |
CLA1170 |
|
1043556-46-2 |
Gantenerumab (Anti-Amyloid β) 95+% |
— | |
CL2148 |
|
93479-97-1 |
Glimepiride 98+% |
C24H34N4O5S | |
CL1166 |
|
603148-36-3 |
Azeliragon (TTP488) 98+% |
C32H38ClN3O2 | |
HL1027 |
|
4429-63-4 |
Tabersonine 98+% |
C21H24N2O2 | |
CLP1096 |
|
107761-42-2 |
Amyloid β-Peptide (1-42),human; β-Amyloid (1-42),human 98+% |
C203H311N55O60S | |
CLP1097 |
|
166090-74-0 |
Amyloid β-peptide (1-42), rat; β-Amyloid (1-42),rat 98+% |
— | |
CLR1002 |
|
128446-35-5 |
HP-β-CD(Hydroxypropyl-β-cyclodextrin) 98+% |
C42H70-nO35(C3H8O2)n | |